Business
CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine – The Motley Fool Australia
Australian global biotech giant, CSL Limited didn’t win the sprint for a coronavirus vaccine. But it may lead the marathon.
The CSL Limited(ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.
That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.
With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.
…
-
General22 hours agoJannik Sinner reveals secret Wimbledon bet that could keep Darren Cahill in his team
-
Business23 hours agoThe pros and cons of buying Accent shares after its decline
-
Noosa News21 hours agoCFMEU violence cost Queensland government $22 million on one job site, premier says
-
General23 hours agoResearchers map key north-south divide in Australia’s orca population